Established in 2016, Changzhou Liren Medical Technology Co., Ltd. is a pharmaceutical enterprise engaged in the innovations of pharmaceuticals, essences, fragrances, new materials and intermediates, as well as the research, production and promotion of high-quality products. Headquartered in Changzhou, our research and development head office owns a number of Ph.D.  and masters, and establishes long-term relations of cooperation in production, education and research with well-known universities in China. At present, we have built 6 production bases in Jiangsu (comprehensive factory), Henan (chlorine), Hebei (chlorine), Shanxi (nitrification), Hubei (chlorine, light, comprehensive) and Shandong (comprehensive factory) separately. Thus we have good ability to undertake the research, development and production of various products.

In the practice of market competition, Liren works hard to build core competitiveness through taking innovation as the driving force. Each year, our company invests more than 30% of profits as research and development funds in the development and production of new products. Following the market demands closely, we have co-produced a series of hot-sales products, including M-hydroxybenzaldehyde (100 tons), P-hydroxybenzaldehyde (1,000 tons), O-nitrobenzaldehyde (500 tons), m-nitrobenzaldehyde (300 tons), climbazole (1,000 tons), allyl amyl glycolate (2,000 tons), p-chlorophenol (10,000 tons), 2-chloropropionic acid (800 tons), Methyl 2-chloropropionate/ethyl 2-chloropropionate (3,000 tons).

Adhering to the principle of "honest and trustworthy, quality first" and sticking to the concept of "high precision top, short adaptable fast", Liren strives for progress, dares to make innovation, work together, and constantly achieve new leapfrogging and new breakthroughs in the development of enterprise.

Our skilled reactions: chlorination, fluorination, bromination, hydrogenation, Friedel-Crafts alkylation, ammoniation, nitration, nitrosation, and conventional reactions.